No description available.

Depression is a major mental health problem for women. Several lines of evidence suggest that fluctuating levels of estrogen associated with various reproductive events are related to changes in mood. It has been hypothesized that estrogen may exert its influence on mood via its effect on the serotonergic system---a system frequently implicated in the regulation of mood. The major goal of the following study was to elucidate further the role of estrogen in mood regulation. To this end, we examined the role of estrogen in the mood-lowering effect of Acute Tryptohpan Deption (ATD), a technique designed to cause a marked lowering of plasma and brain tryptophan, and therefore brain serotonin levels, so that the effects of decreased serotonin on mood can be studied directly. We hypothesized that (1) exogenous estrogen may protect against the mood-lowering effects of ATD in postmenopausal women and that (2) a history of affective disturbance, particularly reproduction-related affective disturbance, would be associated with greater vulnerability to ATD as predicted by the kindling model of depression. Fifty-eight postmenopausal women were randomly assigned to treatment with estrogen (0.625 mg Premarin) or placebo in the context of prospective, double-blind, cross-over design. During the final two week sof the 12-week treatment phase, all participants completed one ATD test session and one nutritionally balanced amino acid control session. We found that: (1) treatment with exogenous estrogen significantly improved mood and menopausal symptoms as compared to placebo treatment, (2) ATD was associated with a significant lowering of mood in both groups, (3) treatment with estrogen did not protect women from ATD effects unless they responded to 11 weeks of treatment with exogenous estrogen with enhanced mood, and (4) a history of reproduction-related affective disturbance was associated with more dysphoric mood in response to ATD. In conclusion, these data provide further evi